(Q39365450)

11 September 2017

title

Predictive value of circulating tumor cells (CTCs) in newly-diagnosed and recurrent ovarian cancer patients (English)

1 reference

11 September 2017

1 reference

6

Ursula A Matulonis

1 reference

11 September 2017

Joyce F Liu

1

1 reference

11 September 2017

David Kindelberger

2

1 reference

11 September 2017

Courtney Doyle

3

1 reference

11 September 2017

Alarice Lowe

4

1 reference

11 September 2017

William T Barry

5

1 reference

11 September 2017

language of work or name

English

0 references

publication date

13 August 2013

1 reference

11 September 2017

1 reference

11 September 2017

volume

131

1 reference

11 September 2017

issue

2

1 reference

11 September 2017

page(s)

352-356

1 reference

11 September 2017

cites work

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.006

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.006

Use of CA-125 to Assess Response to New Agents in Ovarian Cancer Trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.006

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.006

Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.006

Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.006

Circulating tumor cells in the peripheral blood and bone marrow of patients with ovarian carcinoma do not predict prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.006

Phase II trial of the mTOR inhibitor, temsirolimus and evaluation of circulating tumor cells and tumor biomarkers in persistent and recurrent epithelial ovarian and primary peritoneal malignancies: a Gynecologic Oncology Group study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.006

Circulating tumor cells predict progression free survival and overall survival in patients with relapsed/recurrent advanced ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.006

Circulating tumor cells: not all detected cells are bad and not all bad cells are detected

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.006

Preoperative detection of peripherally circulating cancer cells and its prognostic significance in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.006

Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.006

Molecular profiling and prognostic relevance of circulating tumor cells in the blood of ovarian cancer patients at primary diagnosis and after platinum-based chemotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.006

Molecular characterization of circulating tumor cells in patients with ovarian cancer improves their prognostic significance -- a study of the OVCAD consortium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.08.006

10.1016/J.YGYNO.2013.08.006

7 January 2021

Identifiers

DOI

1 reference

release_fo6wadixofc5rjsacprg2teeqa

11 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fo6wadixofc5rjsacprg2teeqa

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference